Pa. tells providers to stop Johnson & Johnson shots while FDA reviews rare complications
Pa. tells providers to stop Johnson & Johnson shots while FDA reviews rare blood clotting cases Updated 2:01 PM; All Pennsylvania COVID-19 vaccine providers should pause giving doses of the Johnson & Johnson vaccine for at least a week, on the heels of a Tuesday recommendation from federal health officials, the state Health Department said The department is taking the precautionary step as the Federal Drug Administration and Centers for Disease Control and Prevention review the cases of six women between the ages of 18 and 48, who had potentially serious blood clots 6 to 13 days after vaccin...